Don’t let the high cost of brand monthly schizophrenia and bipolar I injection disrupt your treatment. We help eligible patients access Abilify Maintena (aripiprazole extended-release IM injection) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Abilify Maintena Patient Assistance Program helps eligible patients access this monthly aripiprazole injectable at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Abilify Maintena PAP enrollment for a flat $69.95 per month — so you never face a gap in Abilify Maintena schizophrenia or bipolar I therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Abilify Maintena enrollment — so you never face a gap in your monthly injectable psychiatric therapy.
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic oral aripiprazole | ~$15/mo | Very cheap oral alt |
| Specialty pharmacy | ~$1,800/mo | Save substantially |
| Psychiatric clinic | ~$2,000/mo | Save substantially |
| Hospital pharmacy | ~$2,200/mo | Save substantially |
| 340B community mental health | ~$1,500/mo | Save substantially |
| Abilify Asimtufii (every 2 mo) | ~$4,000/2-mo | Longer-interval alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Abilify Maintena — independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Abilify Maintena Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Monthly LAI improves adherence dramatically vs daily oral therapy. After stabilization on Maintena, patients may transition to every-2-month Abilify Asimtufii for even less frequent visits.
Complete a simple eligibility form so our team can determine if you may qualify for Abilify Maintena assistance.
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Once approved, your Abilify Maintena is delivered through the assistance program while we manage refills and annual renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Abilify Maintena:
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $1,800–$2,200/mo per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Fixed $69.95/month — never changes regardless of retail price
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Abilify Maintena assistance.
Abilify Maintena is monthly IM long-acting injectable aripiprazole — the standard starting aripiprazole LAI. Improves adherence vs daily oral therapy. Can transition to every-2-month Abilify Asimtufii after tolerability confirmation.
How It Works:
Adherence to daily oral antipsychotic medications is a major challenge in schizophrenia and bipolar disorder — nonadherence drives relapse, hospitalization, and poor long-term outcomes. Long-acting injectable (LAI) antipsychotics ensure therapeutic drug levels for weeks to months. Aripiprazole is a partial dopamine D2 receptor agonist and 5-HT1A partial agonist / 5-HT2A antagonist — atypical antipsychotic with favorable metabolic profile, less prolactin elevation, less sedation, but akathisia common. Abilify Maintena is the monthly IM aripiprazole LAI formulation. Related Aristada uses aripiprazole lauroxil ester. Abilify Asimtufii extends dosing interval to every 2 months.
Form and Use:
Abilify Maintena IM injection in gluteal or deltoid muscle every month. Loading options: two injections on same day (400 mg gluteal + oral aripiprazole 14-day overlap), or single dose with oral aripiprazole 14-day overlap. Then monthly maintenance. Given at psychiatric clinic or community mental health center.
Generic Availability:
No generic Abilify Maintena. Related aripiprazole LAIs: Abilify Asimtufii (every-2-month IM — brand), Aristada (aripiprazole lauroxil monthly IM — brand). Oral aripiprazole (generic — very cheap). Other long-acting injectable antipsychotics: paliperidone family — Invega Sustenna (monthly IM), Invega Trinza (3-monthly IM), Invega Hafyera (6-monthly IM); Risperdal Consta, Perseris, Uzedy, Zyprexa Relprevv. Multiple oral antipsychotic generics: risperidone, olanzapine, quetiapine, aripiprazole, paliperidone. Community mental health centers often provide LAI programs.
Warnings:
Increased mortality in elderly patients with dementia-related psychosis (BOXED WARNING for all antipsychotics — not approved for this indication), suicidal thoughts and behaviors in young adults, neuroleptic malignant syndrome (rare but serious), tardive dyskinesia, metabolic effects, akathisia (common with aripiprazole), impulse control problems (pathologic gambling, compulsive shopping, hypersexuality, binge eating), orthostatic hypotension. Other: injection site reactions, weight gain (less than other antipsychotics), sedation, insomnia. Long-acting formulation means effects may persist weeks after last dose. Coordinate with psychiatrist.
$1,800–$2,200 per monthly injection at specialty pharmacies or psychiatric clinics ($20,000+ annually). Generic oral aripiprazole $10–$20 per month. LAI advantage is adherence, not cost per month.
Same aripiprazole molecule. Abilify Maintena monthly IM injection guarantees therapeutic drug levels for 30 days — eliminates daily pill-taking and addresses adherence challenges. Generic oral aripiprazole is very cheap for patients preferring daily pills.
Same aripiprazole molecule. Abilify Maintena is monthly IM. Abilify Asimtufii is every-2-month IM — longest-interval aripiprazole LAI. Starting LAI is typically Abilify Maintena; may transition to Asimtufii after tolerability confirmation (6 visits/year vs 12).
Both long-acting aripiprazole. Abilify Maintena is aripiprazole itself. Aristada is aripiprazole lauroxil (prodrug ester). Aristada offers monthly, every-6-week, or every-2-month dosing. Both effective; choice by prescriber preference.
Different antipsychotics. Aripiprazole (Abilify Maintena) is partial D2 agonist — favorable metabolic profile, less prolactin, akathisia common. Paliperidone (Invega Sustenna) is D2/5-HT2A antagonist — more prolactin. Both monthly IM LAIs. Choice by tolerability and prescriber preference.
Monthly injectable psychiatric therapy transforms adherence and outcomes. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.
Afford My Prescriptions Powered by Trust Right RX is a nationwide prescription advocacy service helping individuals apply for Patient Assistance Programs